Howard, N., Afolabi, M., Ishola, D., Manno, D., Keshinro, B., Bockstal, V., . . . HEALTH), D. O. (. S. O. P. (2023). Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: A randomised, double-blind, controlled trial. Elsevier BV.
Chicago Style CitationHoward, Natasha, et al. Safety and Immunogenicity of the Two-dose Heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccine Regimen in Children in Sierra Leone: A Randomised, Double-blind, Controlled Trial. Elsevier BV, 2023.
MLA引文Howard, Natasha, et al. Safety and Immunogenicity of the Two-dose Heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccine Regimen in Children in Sierra Leone: A Randomised, Double-blind, Controlled Trial. Elsevier BV, 2023.